(Q33746281)

29 July 2017

Duration of the protective effect of polyaspartic acid on experimental gentamicin nephrotoxicity (English)

1 reference

29 July 2017

0 references

Swan SK

1

1 reference

29 July 2017

Gilbert DN

2

1 reference

29 July 2017

Kohlhepp SJ

3

1 reference

29 July 2017

Leggett JE

4

1 reference

29 July 2017

Kohnen PW

5

1 reference

29 July 2017

Bennett WM

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1992

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

1 reference

29 July 2017

36

1 reference

29 July 2017

11

1 reference

29 July 2017

2556-2558

1 reference

Attenuation of experimental tobramycin nephrotoxicity by ticarcillin

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284375

Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (3). Protective effect of latamoxef against tobramycin nephrotoxicity and its protective mechanism

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284375

Polyaspartic acid protects against gentamicin nephrotoxicity in the rat.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284375

Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (9): Protective effect of inositol hexasulfate against tobramycin-induced nephrotoxicity

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284375

Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284375

Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284375

Effect of dextran sulfate on renal accumulation of gentamicin

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284375

Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5'-phosphate in the rat

14 July 2018

1 reference

12 December 2020

Inhibition of renal membrane binding and nephrotoxicity of gentamicin by polyasparagine and polyaspartic acid in the rat

1 reference

12 December 2020

Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid

1 reference

12 December 2020

Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.36.11.2556

1 reference

release_wq5uk452ebg7zemg2w7heupdua

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wq5uk452ebg7zemg2w7heupdua

24 November 2022

mapped directly with Wikidata item

PMCID

284375

1 reference

29 July 2017

1 reference